2024 - Medical Science Liaisons Deal in the Currency of Information: How Are You Cashing In?

This webinar will unravel the challenges in quantifying medical science liaisons’ value, explore how they are enhancing impact through strategic engagement, unpack new ways of measuring value beyond output and illustrate how companies can further empower medical science liaisons with data-driven artificial intelligence (AI)/tech-enabled solutions.
While the medical science liaison role is expanding across all stages of pharmaceutical development and to encompass a growing number of audiences, the industry is struggling to measure the impact of medical science liaison activities. However, the race is on to develop the right key performance indicators, training, measurement tools and processes for gauging the impact of medical science liaison teams and ultimately improving outcomes.
Medical science liaisons within pharmaceutical companies deal in a special currency: scientific exchange and real-world insights gathering. Only they can share certain types of information with a growing number of medical stakeholders and provide medical insights to guide strategic development and brand decisions.
In this webinar, the attendees will learn about how medical science liaisons can strategically engage with a variety of stakeholders to gather critical insights that shape medical strategies and influence development decisions; discover how customized solutions, such as AI-driven sentiment analysis and insights reporting, can enhance medical science liaisons’ capabilities; and explore innovative methods for assessing the impact of medical science liaisons’ activities.
Do not miss this opportunity to gain actionable strategies for maximizing the value of medical science liaisons and driving better outcomes in pharmaceutical development.
Keywords: Real-World Data, Patient Outcomes, Real-World Evidence, Medical Affairs, Marketing, Medical Science Liaison, AI, RWE, Commercialization/HEOR/Market Access, Other Research, RWD